by Ted Rogers Centre for Heart Research | May 11, 2021 | Education & Training, Equitable Access to Care, Investigating Heart Failure, Personalized Medicine, Why Heart Failure
TRANSFORM HF: digital innovation for heart failure care
by Ted Rogers Centre for Heart Research | Feb 22, 2021 | Equitable Access to Care, Investigating Heart Failure, Personalized Medicine, Translating Innovation
Studying how Apple Watch can keep HF patients safe
by Ted Rogers Centre for Heart Research | Feb 3, 2021 | Equitable Access to Care, Investigating Heart Failure, Personalized Medicine, Translating Innovation
Measuring strain key to detecting CV damage by chemotherapy
by Ted Rogers Centre for Heart Research | Sep 16, 2020 | Equitable Access to Care, Personalized Medicine, Translating Innovation
“It’s a tremendous opportunity”
by Ted Rogers Centre for Heart Research | Sep 1, 2020 | Education & Training, Equitable Access to Care, Investigating Heart Failure, Personalized Medicine
Blockbuster presentation at ESC 2020
by Ted Rogers Centre for Heart Research | Jun 17, 2020 | Equitable Access to Care, Funding Opportunities, Investigating Heart Failure, Personalized Medicine
The first sign of Brugada syndrome is often sudden death
by Ted Rogers Centre for Heart Research | May 24, 2020 | Equitable Access to Care, Personalized Medicine
We must tailor research and care accordingly
by Ted Rogers Centre for Heart Research | May 18, 2020 | Education & Training, Equitable Access to Care, Personalized Medicine, Translating Innovation
Risk calculator is a ‘much-needed’ precision strategy
by Ted Rogers Centre for Heart Research | Apr 8, 2020 | Equitable Access to Care, Personalized Medicine, Translating Innovation, Why Heart Failure
Medly cuts re-hospitalizations for heart failure by 50%
by Ted Rogers Centre for Heart Research | Feb 12, 2020 | Equitable Access to Care, Personalized Medicine, Why Heart Failure
Direct translation from research to clinic